1052 related articles for article (PubMed ID: 33296685)
1. SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation.
Lederer K; Castaño D; Gómez Atria D; Oguin TH; Wang S; Manzoni TB; Muramatsu H; Hogan MJ; Amanat F; Cherubin P; Lundgreen KA; Tam YK; Fan SHY; Eisenlohr LC; Maillard I; Weissman D; Bates P; Krammer F; Sempowski GD; Pardi N; Locci M
Immunity; 2020 Dec; 53(6):1281-1295.e5. PubMed ID: 33296685
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses.
Alameh MG; Tombácz I; Bettini E; Lederer K; Sittplangkoon C; Wilmore JR; Gaudette BT; Soliman OY; Pine M; Hicks P; Manzoni TB; Knox JJ; Johnson JL; Laczkó D; Muramatsu H; Davis B; Meng W; Rosenfeld AM; Strohmeier S; Lin PJC; Mui BL; Tam YK; Karikó K; Jacquet A; Krammer F; Bates P; Cancro MP; Weissman D; Luning Prak ET; Allman D; Locci M; Pardi N
Immunity; 2021 Dec; 54(12):2877-2892.e7. PubMed ID: 34852217
[TBL] [Abstract][Full Text] [Related]
3. High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells.
Chen JS; Chow RD; Song E; Mao T; Israelow B; Kamath K; Bozekowski J; Haynes WA; Filler RB; Menasche BL; Wei J; Alfajaro MM; Song W; Peng L; Carter L; Weinstein JS; Gowthaman U; Chen S; Craft J; Shon JC; Iwasaki A; Wilen CB; Eisenbarth SC
Sci Immunol; 2022 Feb; 7(68):eabl5652. PubMed ID: 34914544
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.
Turner JS; O'Halloran JA; Kalaidina E; Kim W; Schmitz AJ; Zhou JQ; Lei T; Thapa M; Chen RE; Case JB; Amanat F; Rauseo AM; Haile A; Xie X; Klebert MK; Suessen T; Middleton WD; Shi PY; Krammer F; Teefey SA; Diamond MS; Presti RM; Ellebedy AH
Nature; 2021 Aug; 596(7870):109-113. PubMed ID: 34182569
[TBL] [Abstract][Full Text] [Related]
5. Viral Replicative Capacity, Antigen Availability via Hematogenous Spread, and High T
Eldi P; Chaudhri G; Nutt SL; Newsome TP; Karupiah G
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626686
[TBL] [Abstract][Full Text] [Related]
6. Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection.
Cui D; Tang Y; Jiang Q; Jiang D; Zhang Y; Lv Y; Xu D; Wu J; Xie J; Wen C; Lu L
Front Immunol; 2021; 12():731100. PubMed ID: 34603308
[TBL] [Abstract][Full Text] [Related]
7. A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants.
Schmitz AJ; Turner JS; Liu Z; Zhou JQ; Aziati ID; Chen RE; Joshi A; Bricker TL; Darling TL; Adelsberg DC; Altomare CG; Alsoussi WB; Case JB; VanBlargan LA; Lei T; Thapa M; Amanat F; Jeevan T; Fabrizio T; O'Halloran JA; Shi PY; Presti RM; Webby RJ; Krammer F; Whelan SPJ; Bajic G; Diamond MS; Boon ACM; Ellebedy AH
Immunity; 2021 Sep; 54(9):2159-2166.e6. PubMed ID: 34464596
[TBL] [Abstract][Full Text] [Related]
8. Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques.
Helmold Hait S; Vargas-Inchaustegui DA; Musich T; Mohanram V; Tuero I; Venzon DJ; Bear J; Rosati M; Vaccari M; Franchini G; Felber BK; Pavlakis GN; Robert-Guroff M
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463978
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans.
Mudd PA; Minervina AA; Pogorelyy MV; Turner JS; Kim W; Kalaidina E; Petersen J; Schmitz AJ; Lei T; Haile A; Kirk AM; Mettelman RC; Crawford JC; Nguyen THO; Rowntree LC; Rosati E; Richards KA; Sant AJ; Klebert MK; Suessen T; Middleton WD; ; Wolf J; Teefey SA; O'Halloran JA; Presti RM; Kedzierska K; Rossjohn J; Thomas PG; Ellebedy AH
Cell; 2022 Feb; 185(4):603-613.e15. PubMed ID: 35026152
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Omicron boosting induces de novo B cell response in humans.
Alsoussi WB; Malladi SK; Zhou JQ; Liu Z; Ying B; Kim W; Schmitz AJ; Lei T; Horvath SC; Sturtz AJ; McIntire KM; Evavold B; Han F; Scheaffer SM; Fox IF; Mirza SF; Parra-Rodriguez L; Nachbagauer R; Nestorova B; Chalkias S; Farnsworth CW; Klebert MK; Pusic I; Strnad BS; Middleton WD; Teefey SA; Whelan SPJ; Diamond MS; Paris R; O'Halloran JA; Presti RM; Turner JS; Ellebedy AH
Nature; 2023 May; 617(7961):592-598. PubMed ID: 37011668
[TBL] [Abstract][Full Text] [Related]
11. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.
Pardi N; Hogan MJ; Naradikian MS; Parkhouse K; Cain DW; Jones L; Moody MA; Verkerke HP; Myles A; Willis E; LaBranche CC; Montefiori DC; Lobby JL; Saunders KO; Liao HX; Korber BT; Sutherland LL; Scearce RM; Hraber PT; Tombácz I; Muramatsu H; Ni H; Balikov DA; Li C; Mui BL; Tam YK; Krammer F; Karikó K; Polacino P; Eisenlohr LC; Madden TD; Hope MJ; Lewis MG; Lee KK; Hu SL; Hensley SE; Cancro MP; Haynes BF; Weissman D
J Exp Med; 2018 Jun; 215(6):1571-1588. PubMed ID: 29739835
[TBL] [Abstract][Full Text] [Related]
12. Follicular T cells optimize the germinal center response to SARS-CoV-2 protein vaccination in mice.
Cavazzoni CB; Hanson BL; Podestà MA; Bechu ED; Clement RL; Zhang H; Daccache J; Reyes-Robles T; Hett EC; Vora KA; Fadeyi OO; Oslund RC; Hazuda DJ; Sage PT
Cell Rep; 2022 Feb; 38(8):110399. PubMed ID: 35139367
[TBL] [Abstract][Full Text] [Related]
13. A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice.
Coria LM; Saposnik LM; Pueblas Castro C; Castro EF; Bruno LA; Stone WB; Pérez PS; Darriba ML; Chemes LB; Alcain J; Mazzitelli I; Varese A; Salvatori M; Auguste AJ; Álvarez DE; Pasquevich KA; Cassataro J
Front Immunol; 2022; 13():844837. PubMed ID: 35296091
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
[TBL] [Abstract][Full Text] [Related]
15. Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19.
Lozano-Rodríguez R; Valentín-Quiroga J; Avendaño-Ortiz J; Martín-Quirós A; Pascual-Iglesias A; Terrón-Arcos V; Montalbán-Hernández K; Casalvilla-Dueñas JC; Bergón-Gutiérrez M; Alcamí J; García-Pérez J; Cascajero A; García-Garrido MÁ; Balzo-Castillo ÁD; Peinado M; Gómez L; Llorente-Fernández I; Martín-Miguel G; Herrero-Benito C; Benito JM; Rallón N; Vela-Olmo C; López-Morejón L; Cubillos-Zapata C; Aguirre LA; Fresno CD; López-Collazo E
Cell Rep; 2022 Jan; 38(2):110235. PubMed ID: 34986327
[TBL] [Abstract][Full Text] [Related]
16. Tfh cells and the germinal center are required for memory B cell formation & humoral immunity after ChAdOx1 nCoV-19 vaccination.
Foster WS; Lee JL; Thakur N; Newman J; Spencer AJ; Davies S; Woods D; Godfrey L; Hay IM; Innocentin S; Yam-Puc JC; Horner EC; Sharpe HJ; Thaventhiran JE; Bailey D; Lambe T; Linterman MA
Cell Rep Med; 2022 Dec; 3(12):100845. PubMed ID: 36455555
[TBL] [Abstract][Full Text] [Related]
17. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.
Laczkó D; Hogan MJ; Toulmin SA; Hicks P; Lederer K; Gaudette BT; Castaño D; Amanat F; Muramatsu H; Oguin TH; Ojha A; Zhang L; Mu Z; Parks R; Manzoni TB; Roper B; Strohmeier S; Tombácz I; Arwood L; Nachbagauer R; Karikó K; Greenhouse J; Pessaint L; Porto M; Putman-Taylor T; Strasbaugh A; Campbell TA; Lin PJC; Tam YK; Sempowski GD; Farzan M; Choe H; Saunders KO; Haynes BF; Andersen H; Eisenlohr LC; Weissman D; Krammer F; Bates P; Allman D; Locci M; Pardi N
Immunity; 2020 Oct; 53(4):724-732.e7. PubMed ID: 32783919
[TBL] [Abstract][Full Text] [Related]
18. Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination.
Goel RR; Apostolidis SA; Painter MM; Mathew D; Pattekar A; Kuthuru O; Gouma S; Hicks P; Meng W; Rosenfeld AM; Dysinger S; Lundgreen KA; Kuri-Cervantes L; Adamski S; Hicks A; Korte S; Oldridge DA; Baxter AE; Giles JR; Weirick ME; McAllister CM; Dougherty J; Long S; D'Andrea K; Hamilton JT; Betts MR; Luning Prak ET; Bates P; Hensley SE; Greenplate AR; Wherry EJ
Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33858945
[TBL] [Abstract][Full Text] [Related]
19. Rapid induction of antigen-specific CD4
Painter MM; Mathew D; Goel RR; Apostolidis SA; Pattekar A; Kuthuru O; Baxter AE; Herati RS; Oldridge DA; Gouma S; Hicks P; Dysinger S; Lundgreen KA; Kuri-Cervantes L; Adamski S; Hicks A; Korte S; Giles JR; Weirick ME; McAllister CM; Dougherty J; Long S; D'Andrea K; Hamilton JT; Betts MR; Bates P; Hensley SE; Grifoni A; Weiskopf D; Sette A; Greenplate AR; Wherry EJ
Immunity; 2021 Sep; 54(9):2133-2142.e3. PubMed ID: 34453880
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people.
Narowski TM; Raphel K; Adams LE; Huang J; Vielot NA; Jadi R; de Silva AM; Baric RS; Lafleur JE; Premkumar L
Cell Rep; 2022 Feb; 38(5):110336. PubMed ID: 35090596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
